Evaluate life sciences opportunities faster, with expert-reviewed rigor.
Venture Stage Lens (VSL) helps founders, investors, and innovation organizations assess complex opportunities across pharma, healthtech, medtech, agrotech, and foodtech through AI-assisted, expert-reviewed analysis. We deliver structured, decision-useful outputs that reduce time burden, improve clarity, and preserve accountability.
Founders
We provide an external diagnosis of where an opportunity truly stands, helping founders calibrate their stage, strengthen first impressions with investors, and identify the next steps needed to move forward.
Learn more
Investors
We reduce the burden of high-volume, research-heavy evaluation work, helping investors assess opportunities more efficiently while complementing their existing diligence systems.
Learn more
Innovation organizations
We support resource allocation, project selection, and planning by helping organizations determine which opportunities to advance and what each one needs next.
Learn moreWe help clients assess complex opportunities through a process built for clarity, rigor, and accountability.
How we work
Review documentation
We begin by reviewing the opportunity as it is currently positioned, evaluating whether the underlying science, maturity, and overall readiness align with the stage it claims to be at. From there, we assess the opportunity across key dimensions, including technical credibility, differentiation, development pathway, strategic relevance, and venture potential.
AI-optimized, Human-verified
Our process is AI-assisted to improve speed and consistency, but every deliverable is reviewed by a human with relevant domain expertise before release. This allows us to move efficiently without sacrificing judgment or accountability.Risk Report and Next Steps
The final output is designed to be both diagnostic and practical: a clear view of where the opportunity stands today, the main gaps or risks that need to be addressed, and the next steps that can help move it forward.